169 related articles for article (PubMed ID: 25730680)
1. Current treatments and preventive strategies for radiation retinopathy.
Reichstein D
Curr Opin Ophthalmol; 2015 May; 26(3):157-66. PubMed ID: 25730680
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
Finger PT; Chin K
Arch Ophthalmol; 2007 Jun; 125(6):751-6. PubMed ID: 17562985
[TBL] [Abstract][Full Text] [Related]
3. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
4. Current treatments for radiation retinopathy.
Giuliari GP; Sadaka A; Hinkle DM; Simpson ER
Acta Oncol; 2011 Jan; 50(1):6-13. PubMed ID: 20722590
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy.
Finger PT; Mukkamala SK
Eur J Ophthalmol; 2011; 21(4):446-51. PubMed ID: 21218391
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO; Albert MA; Persaud TO; Vail RS
Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
9. Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma.
Wen JC; McCannel TA
Curr Opin Ophthalmol; 2009 May; 20(3):200-4. PubMed ID: 19349865
[TBL] [Abstract][Full Text] [Related]
10. High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy.
Finger PT; Chin KJ
Eur J Ophthalmol; 2013; 23(6):850-6. PubMed ID: 23813109
[TBL] [Abstract][Full Text] [Related]
11. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF Therapy Immediately after Plaque Radiation Therapy Prevents or Delays Radiation Maculopathy.
Powell BE; Finger PT
Ophthalmol Retina; 2020 May; 4(5):547-550. PubMed ID: 32192938
[No Abstract] [Full Text] [Related]
13. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
15. Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.
Tarmann L; Langmann G; Mayer C; Weger M; Haas A; Wackernagel W
Acta Ophthalmol; 2014 Dec; 92(8):e694-6. PubMed ID: 24739457
[No Abstract] [Full Text] [Related]
16. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
17. Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):789-98. PubMed ID: 21277107
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
Nagendran ST; Finger PT
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
[TBL] [Abstract][Full Text] [Related]
19. Anti-Vascular Endothelial Growth Factor Therapy for Radiation Retinopathy.
Rayess N; Mruthyunjaya P
Ophthalmic Surg Lasers Imaging Retina; 2020 Apr; 51(4):S44-S49. PubMed ID: 32348534
[TBL] [Abstract][Full Text] [Related]
20. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin).
Finger PT
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):974-7. PubMed ID: 18313522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
